The quantified self movement just got uncomfortably personal. Biohacker Bryan Johnson recently posted about his girlfriend having a "top 1%" vagina based on at-home microbiome testing, and apparently he's not alone in this obsession.
At-home vaginal microbiome testing has become a real industry. Companies are selling kits that promise to help women "optimize" their vaginal health through detailed bacterial analysis. The pitch is familiar to anyone in the biohacking space: measure everything, optimize everything.
But medical experts are pumping the brakes. The science behind these tests and their recommendations isn't as solid as the marketing suggests. Unlike gut microbiome research, which has years of data behind it, vaginal microbiome optimization is still in early stages.
This matters because it's part of a larger pattern we're seeing in health tech. Companies are racing to quantify and optimize every aspect of human biology, often before the science catches up. The same impulse that drives people to track their sleep, glucose, and heart rate variability is now extending into more intimate territory.
The risk isn't just wasted money on unproven tests. It's that people might make health decisions based on incomplete or misinterpreted data. When optimization culture meets intimate health, the stakes get higher and the need for solid science becomes even more critical.
